Serum NGAL to Clinically Distinguish Cholangiocarcinoma from Benign Biliary Tract Diseases

Table 1

Clinical characteristics of patients with benign biliary tract diseases (control) and cholangiocarcinoma.

	Control 𝑁=50	Cholangiocarcinoma 𝑁=50	P value
Age (yr)	61±17	60±9	.898
Sex (male : female)	15 : 35	19 : 31	.527
Albumin (mg/dL)	3.9±0.73	3.0±0.55	<.001
BUN (mg/dL)	14.7±8.40	22.3±28.74	0.107
Creatinine (mg/dL)	0.9±0.75	1.1±1.16	0.358
Globulin (mg/dL)	3.8±0.69	4.1±0.94	0.098
Total bilirubin (mg/dL)	2.7 ± 4.13	13.6 ± 11.56	<.001
AST (U/L)	63.4±95.80	103.3±77.77	0.001
ALT (U/L)	62.1±80.13	56.8±44.54	0.188
ALP (U/L)	253.5±319.22	411.7±312.60	<.001